STOCK TITAN

Soleus discloses 2.55M Vericel shares (NASDAQ: VCEL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Vericel Corp reports that Soleus Capital Master Fund, L.P. and affiliated entities hold 2,549,079 shares of common stock. The filing states this equals 5.0% of Vericel's outstanding common shares, based on 50,763,319 shares outstanding as of February 19, 2026. The ownership is reported as shared voting and dispositive power among the fund and affiliated entities, with Guy Levy identified as the managing member signing the joint filing agreement.

Positive

  • None.

Negative

  • None.

Insights

Soleus-owned stake: a disclosed passive 5.0% position in Vericel.

The Schedule 13G lists 2,549,079 shares (5.0%) held by Soleus Capital Master Fund, L.P., with shared voting and dispositive power attributed across affiliated entities. The filing follows passive-investor reporting conventions and includes standard disclaimers about beneficial ownership attribution among related entities.

Implications are limited: this is a disclosure of scale rather than an announced strategy. Subsequent Form 13D or material filings would be required to signal active campaigning or change. Future filings may update position size or voting intentions.

Shares beneficially owned 2,549,079 shares Amount reported by Soleus entities
Percent of class 5.0% Calculated using shares outstanding as of <date> February 19, 2026</date>
Shares outstanding 50,763,319 shares Outstanding common stock as of <date> February 19, 2026</date>
Schedule 13G regulatory
"The filing identifies itself as a Schedule 13G disclosure of ownership"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Shared dispositive power regulatory
"Shared Dispositive Power 2,549,079.00 appears in the ownership table"
Beneficial ownership regulatory
"Each party "disclaims beneficial ownership of these shares held by Master Fund" in the footnote"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.





92346J108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus Capital Master Fund, L.P. ("Master Fund"). Soleus Capital, LLC ("Soleus Capital") is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, Soleus Capital Management, L.P. ("SCM") is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 50,763,319 shares of the common stock of Vericel Corporation (the "Issuer") outstanding as of February 19, 2026, as reported on the cover of the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on February 26, 2026 (the "Form 10-K").


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 50,763,319 shares of the common stock of the Issuer outstanding as of February 19, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 50,763,319 shares of the common stock of the Issuer outstanding as of February 19, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 50,763,319 shares of the common stock of the Issuer outstanding as of February 19, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 50,763,319 shares of the common stock of the Issuer outstanding as of February 19, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons \s the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 50,763,319 shares of the common stock of the Issuer outstanding as of February 19, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G



Soleus Capital Master Fund, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:04/01/2026
Soleus Capital, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:04/01/2026
Soleus Capital Group, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:04/01/2026
Soleus Capital Management, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:04/01/2026
Soleus GP, LLC
Signature:Soleus GP, LLC
Name/Title:Guy Levy/Managing Member
Date:04/01/2026
Guy Levy
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:04/01/2026

Comments accompanying signature: Exhibit 99.A - Joint Filing Agreement

FAQ

What stake did Soleus report in Vericel (VCEL)?

Soleus reported ownership of 2,549,079 shares, representing 5.0% of outstanding common stock. The percentage is calculated using 50,763,319 shares outstanding as of February 19, 2026 from the company 10-K cover.

Who is named as having voting power for the Soleus position?

The filing shows shared voting power and shared dispositive power of 2,549,079 shares across Soleus affiliates. Guy Levy is listed as the managing member who signed the joint filing agreement on behalf of the group.

Does the Schedule 13G indicate Soleus is an active or passive investor in VCEL?

The filing is a Schedule 13G-style disclosure indicating a passive investor position. The statement includes standard disclaimers and does not assert active control or activist intentions in this filing.

Which entities filed the joint Schedule 13G for this holding?

The joint filing lists Soleus Capital Master Fund, L.P., Soleus Capital, LLC, Soleus Capital Group, LLC, Soleus Capital Management, L.P., Soleus GP, LLC, and Guy Levy at Soleus' Greenwich, CT address.

What date is used to calculate the percent ownership in the filing?

The percentage is calculated using the outstanding share count reported as of February 19, 2026 on Vericel's Form 10-K cover, which lists 50,763,319 shares outstanding.